Early Diagnosis of Pancreatic Cancer-Network Collaborative Studies

Abbreviated Name
Early Diagnosis of Pancreatic Cancer-Network Collaborative Studies
Lead Investigator
Hollingsworth, Michael — University of Nebraska Medical Center
Coordinating Investigator
Hollingsworth, Michael — University of Nebraska Medical Center
Involved Investigators

Abstact

Aims

Specific Aim 1) Utilize newly developed and to be developed antibodies against the mucin core proteins MUC1, MUC4, and MUC17 to develop an improved serum assay for pancreatic adenocarcinoma. Specific Aim 2) Develop and utilize a set of monoclonal antibodies that recognize serum forms of distinct mucin core proteins, utilize these to improve the diagnostic capability of the CA 19-9 type tests for nonmalignant, premalignant and malignant lesions of the pancreas, and evaluate the capability of the test to discriminate pancreatic cancer from other adenocarcinomas.

Analytic Method

Biomarkers

  • No biomarkers available at this time for this protocol

Data Collections

  • No data available at this time for this protocol
Protocol ID
196
Protocol Type
Collaboration
Field of Research
UNKNOWN
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Malignant neoplasm of pancreas

Associated Forms